- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: glimepiride
Total 239 results
-
Kurume UniversityUnknownEffects of the DPP-4 Inhibitors or SGLT2 Inhibitors on the Protective Actions for Diabetic ComplicationsJapan
-
The Second Hospital of Nanjing Medical UniversityUnknownMicroalbuminuria | Microalbuminuria /Creatinine Ratios ACR
-
Foundation for the National Institutes of HealthEli Lilly and Company; National Institute of Diabetes and Digestive and Kidney... and other collaboratorsUnknown
-
Pusan National University HospitalUnknownType 2 Diabetes MellitusKorea, Republic of
-
LG Life SciencesCompletedType 2 Diabetes MellitusKorea, Republic of
-
SanofiCompletedDiabetes Mellitus, Type 2Algeria, Colombia, Egypt, Guatemala, India, Iran, Islamic Republic of, Lebanon, Mexico, Russian Federation, South Africa, Tunisia, Turkey, Ukraine, United Arab Emirates
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Argentina, India, Australia, Spain, Taiwan, France, Canada, Hungary, Mexico, Croatia, Korea, Republic of, Poland, Greece, Belgium, Brazil, Italy, Czech Republic, Romania, Slovakia, Sweden
-
Vanderbilt UniversityCompleted
-
Gilead SciencesCompletedType 2 Diabetes MellitusUnited States, Russian Federation, Thailand, Serbia, Poland, Hungary, Malaysia, South Africa, Ukraine, Czech Republic, Romania, Slovakia
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2France, Germany, Slovakia, Sweden, Ukraine, United Kingdom
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Australia, Canada, Finland, Israel, Japan, New Zealand, Slovakia, Sweden
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Canada, Mexico, Philippines, Romania, Russian Federation, Ukraine
-
Boehringer IngelheimCompleted
-
Jothydev's Diabetes and Research CentreCompletedDiabetes Mellitus, Type 2India
-
SanofiCompleted
-
SanofiCompletedType 2 Diabetes MellitusLebanon, Russian Federation, Ukraine
-
Mitsubishi Tanabe Pharma CorporationCompletedType 2 Diabetes MellitusJapan
-
Ohio UniversityWestern University of Health SciencesCompletedType 2 DiabetesUnited States
-
Novartis PharmaceuticalsCompletedType 2 Diabetes MellitusChina
-
LG Life SciencesUnknownType 2 Diabetes MellitusKorea, Republic of
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Bulgaria, Denmark, France, Germany, Hong Kong, Hungary, India, Ireland, Italy, Netherlands, Norway, Poland, South Africa, Sweden, United Kingdom
-
AstraZenecaBristol-Myers SquibbCompletedType 2 Diabetes MellitusSweden, Italy, United Kingdom, Finland, Norway, Mexico, Austria, Denmark, Germany, Hungary, Greece, France, Spain
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesCzech Republic, Korea, Republic of, Hungary, Poland, Ukraine, Philippines, Thailand
-
Kyunghee University Medical CenterSanofi; Korea University Guro Hospital; Hanyang University; The Catholic University... and other collaboratorsCompletedType 2 Diabetes Mellitus | Pancreatic Beta Cell Function | GlucotoxicityKorea, Republic of
-
University Hospital, Gentofte, CopenhagenNovo Nordisk A/S; University of CopenhagenCompletedMaturity-onset Diabetes of the YoungDenmark
-
Akros Pharma Inc.CompletedType 2 Diabetes MellitusUnited States
-
LG Life SciencesCompletedHealthyKorea, Republic of
-
Canadian Heart Research CentreGlaxoSmithKlineCompletedType 2 Diabetes MellitusCanada
-
Handok Inc.CompletedType 2 Diabetes MellitusKorea, Republic of
-
Handok Inc.CompletedType 2 Diabetes MellitusKorea, Republic of
-
Kurume UniversityUnknownTo Evaluate the Effect of Pioglitazone on Glucose Metabolism of Fat Tissue by Using FDG-PET/CT ImagingJapan
-
Intarcia TherapeuticsWithdrawnType 2 DiabetesUnited States
-
Intarcia TherapeuticsWithdrawnType 2 DiabetesUnited States
-
Shanghai Jiao Tong University School of MedicineUnknown
-
The Royal Bournemouth HospitalMerck Sharp & Dohme LLCCompletedType 2 Diabetes MellitusUnited Kingdom
-
Kurume UniversityCompletedType 2 Diabetes Mellitus | Atherosclerosis | Impaired Glucose ToleranceJapan
-
Dexa Medica GroupCompletedGlimepiride BE Study in Healthy Volunteers Under Fasting ConditionIndonesia
-
Handok Inc.CompletedType 2 Diabetes MellitusKorea, Republic of
-
SanofiCompletedDiabetes Mellitus, Type 2Brazil, Thailand, Slovakia, Poland, Netherlands, Kuwait, Mexico, Korea, Republic of, Czech Republic, Egypt, France, Italy, Romania, Russian Federation, Sweden, Switzerland, United Arab Emirates
-
TakedaCompleted
-
SanofiCompleted
-
SanofiCompletedType 2 Diabetes MellitusKorea, Republic of
-
Novartis PharmaceuticalsCompletedEfficacy and Safety of Vildagliptin in Combination With Glimepiride in Patients With Type 2 DiabetesDiabetes Mellitus, Type 2United States
-
Marcus BorchertBoehringer Ingelheim; ikfe-CRO GmbHUnknown
-
SanofiCompleted
-
ikfe-CRO GmbHNovartis Pharmaceuticals; IKFE Institute for Clinical Research and DevelopmentUnknown